XML 54 R35.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stockholders’ Equity (Tables)
 12 Months Ended
Dec. 31, 2023
Stockholders' Equity Note [Abstract]  
Schedule of Preferred Stock Dividend Declaration and Payment
The following table presents cash dividends declared by the Company on its Series B Preferred Stock from January 1, 2021 through December 31, 2023:
Year
Declaration Date
Record DatePayment DateDividend Per Share
2023November 21, 2023December 4, 2023December 29, 2023$0.46875
August 17, 2023September 5, 2023September 29, 20230.46875
May 22, 2023June 5, 2023June 30, 20230.46875
February 21, 2023March 6, 2023March 31, 20230.46875
2022November 18, 2022December 5, 2022December 30, 2022$0.46875
August 22, 2022September 6, 2022September 30, 20220.46875
May 18, 2022June 1, 2022June 30, 20220.46875
February 17, 2022March 1, 2022March 31, 20220.46875
2021November 16, 2021December 1, 2021December 31, 2021$0.46875
August 26, 2021September 8, 2021September 30, 20210.46875
May 24, 2021June 7, 2021June 30, 20210.46875
February 19, 2021March 5, 2021March 31, 20210.46875
The following table presents cash dividends declared by the Company on its Series C Preferred Stock from January 1, 2021 through December 31, 2023:

Year
Declaration Date
Record DatePayment DateDividend Per Share
2023November 21, 2023December 4, 2023December 29, 2023$0.40625
August 17, 2023September 5, 2023September 29, 20230.40625
May 22, 2023June 5, 2023June 30, 20230.40625
February 21, 2023March 6, 2023March 31, 20230.40625
2022November 18, 2022December 5, 2022December 30, 2022$0.40625
August 22, 2022September 6, 2022September 30, 20220.40625
May 18, 2022June 1, 2022June 30, 20220.40625
February 17, 2022March 1, 2022March 31, 20220.40625
2021November 16, 2021December 1, 2021December 31, 2021$0.40625
August 26, 2021September 8, 2021September 30, 20210.40625
May 24, 2021June 7, 2021June 30, 20210.40625
February 19, 2021March 5, 2021March 31, 20210.40625
Schedule of Cash Dividends Declared on Common Stock
The following table presents cash dividends declared by the Company on its common stock from January 1, 2021 through December 31, 2023: 
Year
Declaration Date
Record DatePayment DateDividend Per Share 
2023December 13, 2023December 29, 2023January 31, 2024$0.350(1)
September 20, 2023October 2, 2023October 31, 20230.350
June 15, 2023June 30, 2023July 31, 20230.350
March 10, 2023March 31, 2023April 28, 20230.350
2022December 14, 2022December 30, 2022January 31, 2023$0.350(2)
September 13, 2022September 30, 2022October 31, 20220.440
June 15, 2022June 30, 2022July 29, 20220.440
March 11, 2022March 22, 2022April 29, 20220.440(3)
2021December 14, 2021December 31, 2021January 31, 2022$0.440
(4)(5)
September 15, 2021September 30, 2021October 29, 20210.400(4)
June 15, 2021June 30, 2021July 30, 20210.400(4)
March 12, 2021March 31, 2021April 30, 20210.300(4)
 
(1)At December 31, 2023, the Company had accrued dividends and dividend equivalents payable of $35.8 million related to the common stock dividend declared on December 13, 2023. This dividend will be treated as a dividend paid in 2024 to the extent of the Company’s earnings and profits in 2024.
(2)At December 31, 2022, the Company had accrued dividends and dividend equivalents payable of $35.8 million related to the common stock dividend declared on December 14, 2022. A portion of this dividend was considered taxable income to the recipient in 2023. For more information see the Company’s 2023 Dividend Tax Information on its website.
(3)The $0.44 per share dividend declared on March 11, 2022, has been adjusted to reflect the Reverse Stock Split; the amount actually paid in respect of such dividend was $0.11 per share, which was based on the pre-split number of shares held by stockholders at the record date for such dividend (March 22, 2022).
(4)The $0.44, $0.40, $0.40 and $0.30 per share dividend amounts for the three months ended December 31, 2021, September 30, 2021, June 30, 2021 and March 31, 2021, respectively, have been adjusted to reflect the Company’s one-for-four reverse stock split effected on April 4, 2022; the dividends actually paid in respect of such dividends were $0.11, $0.10, $0.10 and $0.075 per share, respectively, which were based on the pre-split number of shares held by stockholders at the record dates for such dividends (December 31, 2021, September 30, 2021, June 30, 2021, and March 31, 2021, respectively).
(5)At December 31, 2021, the Company had accrued dividends and dividend equivalents payable of $47.8 million related to the common stock dividend declared on December 14, 2021. A portion of this dividend was considered taxable income to the recipient in 2022. For more information see the Company’s 2022 Dividend Tax Information on its website.
Schedule of Changes in Balances in Each Component of the Entity's AOCI
The following tables present changes in the balances of each component of the Company’s AOCI for the years ended December 31, 2023, 2022 and 2021:

For the Year Ended December 31, 2023
(In Thousands)Net Unrealized
Gain/(Loss) on
AFS Securities
Net Unrealized Gain/(Loss) on Financing Agreements (1)
Total 
AOCI
Balance at beginning of period$21,341 $— $21,341 
OCI before reclassifications(2,873)— (2,873)
Amounts reclassified from AOCI
(770)— (770)
Net OCI during the period (2)
(3,643)— (3,643)
Balance at end of period$17,698 $— $17,698 

For the Year Ended December 31, 2022
(In Thousands)Net Unrealized
Gain/(Loss) on
AFS Securities
Net Unrealized Gain/(Loss) on Financing Agreements (1)
Total 
AOCI
Balance at beginning of period$46,833 $(1,255)$45,578 
OCI before reclassifications(25,492)1,255 (24,237)
Amounts reclassified from AOCI
— — — 
Net OCI during the period (2)
(25,492)1,255 (24,237)
Balance at end of period$21,341 $— $21,341 

For the Year Ended December 31, 2021
(In Thousands)Net Unrealized
Gain/(Loss) on
AFS Securities
Net Unrealized Gain/(Loss) on Financing Agreements (1)
Total 
AOCI
Balance at beginning of period$79,607 $(2,314)$77,293 
OCI before reclassifications(32,774)1,059 (31,715)
Amounts reclassified from AOCI
— — — 
Net OCI during the period (2)
(32,774)1,059 (31,715)
Balance at end of period$46,833 $(1,255)$45,578 

(1)Net Unrealized Gain/(Loss) on Financing Agreements at Fair Value due to changes in instrument-specific credit risk.
(2)For further information regarding changes in OCI, see the Company’s consolidated statements of comprehensive income/(loss).